Cancers, Vol. 15, Pages 5108: Decoding the Impact of Tumor Microenvironment in Osteosarcoma Progression and Metastasis

Cancers, Vol. 15, Pages 5108: Decoding the Impact of Tumor Microenvironment in Osteosarcoma Progression and Metastasis

Cancers doi: 10.3390/cancers15205108

Authors: Bikesh K. Nirala Taku Yamamichi D. Isabel Petrescu Tasnuva N. Shafin Jason T. Yustein

Osteosarcoma (OS) is a heterogeneous, highly metastatic bone malignancy in children and adolescents. Despite advancements in multimodal treatment strategies, the prognosis for patients with metastatic or recurrent disease has not improved significantly in the last four decades. OS is a highly heterogeneous tumor; its genetic background and the mechanism of oncogenesis are not well defined. Unfortunately, no effective molecular targeted therapy is currently available for this disease. Understanding osteosarcoma’s tumor microenvironment (TME) has recently gained much interest among scientists hoping to provide valuable insights into tumor heterogeneity, progression, metastasis, and the identification of novel therapeutic avenues. Here, we review the current understanding of the TME of OS, including different cellular and noncellular components, their crosstalk with OS tumor cells, and their involvement in tumor progression and metastasis. We also highlight past/current clinical trials targeting the TME of OS for effective therapies and potential future therapeutic strategies with negligible adverse effects.